Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sedation regimens for outpatient colonoscopy
ACTRN12606000503527Phase 4Completed
- Sponsor
- Melbourne Health Research Directorate
- Start
- Dec 2006
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of propofol, midazolam and fentanyl in None (2 arms), sponsored by Melbourne Health Research Directorate. Primary endpoint: Cognitive impairment. Started Dec 2006; status: completed.
02
Drugs
propofolmidazolamfentanyl
Beyond the preview
Go deeper on ACTRN12606000503527.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12606000503527.